New kids on the block want to play

And they’re bringing their own ball.

Inspiration Biopharmaceuticals hopes to get into the recombinant Factor IX (rFIX) game with a new low-cost manufacturing process.

In a November 13, 2007 press release Inspiration Biopharmaceuticals states having a patented manufacturing process that “significantly increase(s) cell-line productivity.” Which, “significantly lowers the overall production cost for Factor products compared with existing manufacturing processes.”

Inspiration Biopharmaceuticals hopes its cost-effective process will open the door to non-invasive delivery methods and eventually to a therapeutic cure for hemophilia B.

Cheaper, better, easier. All desireable. But first and foremost; safety, safety, safety.

Read the press release here.